A Phase 1, Double-Blind (Sponsor Open), Randomised, Placebo-Controlled, Parallel Group, Oral Multiple-Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04457845 In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2011
At a glance
- Drugs PF 4457845 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 02 Nov 2011 Results published in the British Journal of Clinical Pharmacology.
- 07 Aug 2009 Actual number of patients (41) added as reported by ClinicalTrials.gov.
- 07 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.